Name of the Trial WHO Solidarity Trial Title of the Trial Repurposed Antiviral Drugs for Covid-19 Design Open-label, randomized controlled trial Year of Publication 2020…
Title of the Trial PlasmAr: Convalescent Plasma in Covid-19 Severe Pneumonia Year of Publication 2020 Objective To assess if in patients with severe SARS-CoV-2 pneumonia,…
Objective The goal of the HIGH-WEAN trial was to evaluate if high-flow nasal oxygen with noninvasive ventilation, compared with high-flow nasal oxygen alone, decreased the…
Hyponatremia diagnosis can be challenging as serum sodium concentration is affected by wide variety of variables. In order to understand the concept of hyponatremia, we…
Tocilizumab is an antiinflammatory monoclonal antibody that was initially developed for rheumatoid arthritis. Based on its antiinflammatory mecahnism of action, it was hypothesized to have…
VERTIS CV Trial: The SGLT-2 inhibitors are the next generation drugs for type 2 diabetes as well as patients with heart failure. We have seen…
The SGLT-2 inhibitors were initially developed for diabetes but eventually noted to have significant effects on outcomes in patients with heart failure in addition to…
Multiple small trials in the past have shown benefits of liberal transfusion strategy in patients having active MI. However, a large size trial was lacking.…
In patients with nonvalvular afib, rate control was considered to be no different than rhythm control based on the AFFIRM trial results that was published…
EXPLORER HCM Trial Summary: Mavacamten is a novel cardiac-specific myosin ATPase inhibitor. It specifically reduces excessive cross-bridging with actin, which is associated with pathological hypercontractility…